Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Faeth Therapeutics, Inc.

NASDAQ: FTH · Life Sciences · 6 alerts · CIK 1829802

Share price
$9.28Close, Nov 16
Market cap
$240M
Shares outstanding
25.84MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Faeth Therapeutics, Inc. filings on SEC EDGAR ↗

7:34 AM ET 8-K
Leadership Change

Faeth Therapeutics Leadership Change

Faeth Therapeutics increased its board size from six to seven and appointed Adam Schayowitz, Ph.D., as a Class III director. Dr. Schayowitz, currently EVP and Head of R&D at Zymeworks, brings extensive oncology drug development experience from previous roles at Pfizer and Tesaro. He will receive a standard non-employee director compensation package, including an initial option to purchase 25,000 shares of common stock.

4:16 PM ET 8-K
Leadership Change

Faeth Therapeutics Leadership Change

Faeth Therapeutics increased its board size from five to six and appointed co-founder Karen Vousden, Ph.D., as a Class II director and member of the Compensation Committee. Dr. Vousden, a renowned cancer biologist and current director at Bristol Myers Squibb, will receive a standard non-employee director compensation package including an option to purchase 25,000 shares of common stock.

Counterparty
Karen Vousden, Ph.D.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.